Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical settingStefania Bettelli,Raffaella Marcheselli,Samantha Pozzi,Luigi Marcheselli,Robel Papotti,Elisa Forti,M. Christina Christina Cox,Arianna Di Napoli,Tamar Tadmor,Giovanna R. Mansueto,Pellegrino Musto,Leonardo Flenghi, Martina Quintini,Sara Galimberti,Vittoria Lalinga,Valentina Donati,Antonino Maiorana,Aaron Polliack,Stefano SacchiLeukemia Research（2021）引用 5|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
